Patents by Inventor Michael LIPTAY

Michael LIPTAY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140274772
    Abstract: A method and a kit for assessing risk of lung cancer versus benign disease in a subject are provided. The method includes obtaining a biological sample from the subject and determining a measurement for a panel of biomarkers in the biological sample. The panel includes at least two biomarkers selected from the group consisting of IL-6, IL-1ra, IL-10, SDF-1?+?, TNF-?, MIP-1?, sIL-2R?, CA-125, sE-Selectin, Eotaxin, sEGFR, MMP-2, OPN, MCP-1, CRP, sICAM-1 and CYFRA 21.1. The method further includes comparing the measurement to a reference profile for the panel of biomarkers, sorting the subject into a group and determining whether the subject is at risk for lung cancer based on the group.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: Rush University Medical Center
    Inventors: Jeffrey A. BORGIA, Michael LIPTAY